JESSICA DEROCHIE: Open Payments
NPI 1215547245 · NORWICH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,938 in 163 payments from 25 companies in 2025. Trend: 2023 $3,010 · 2024 $2,892 · 2025 $2,938
Food & beverage: $2,938
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $351 |
| Novo Nordisk Inc | 14 | $340 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $269 |
| Lilly USA, LLC | 12 | $224 |
| AstraZeneca Pharmaceuticals LP | 10 | $222 |
| GlaxoSmithKline, LLC. | 14 | $211 |
| Amgen Inc. | 15 | $198 |
| Axsome Therapeutics, Inc. | 5 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $179 |
| Pharmacosmos Therapeutics Inc. | 7 | $163 |
Products named: JARDIANCE, TRELEGY ELLIPTA, Auvelity, CAPLYTA, Ozempic, VRAYLAR, BREZTRI, MONOFERRIC.
Industry payments across NY — which companies pay providers there.
